Insiders / Levy Richard S / Activity
Activity — Levy Richard S
22 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| May 22, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $774.8K | -1K -6.14% | 22,877 0.10% of shares | medium |
| May 22, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $405.7K | -782 -3.42% | 22,095 0.10% of shares | medium |
| May 22, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $373.7K | -723 -2.88% | 24,374 0.11% of shares | medium |
| May 22, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $339.0K | -657 -2.55% | 25,097 0.11% of shares | medium |
| May 22, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $312.0K | -610 -2.24% | 26,576 0.12% of shares | medium |
| May 22, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $225.0K | -439 -1.65% | 26,137 0.11% of shares | medium |
| May 22, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $176.5K | -343 -1.31% | 25,754 0.11% of shares | medium |
| May 22, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $162.6K | -320 -1.16% | 27,337 0.12% of shares | medium |
| May 22, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $77.1K | -151 -0.55% | 27,186 0.12% of shares | low |
| Jan 26, 2026 | Exercise | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $65.8K | +4K +18.87% | 25,197 0.11% of shares | low |
| May 22, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $41.6K | -80 -0.36% | 22,015 0.10% of shares | low |
| May 22, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $20.5K | -40 -0.15% | 26,097 0.11% of shares | low |
| May 22, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $20.3K | -40 -0.14% | 27,657 0.12% of shares | low |
| Feb 23, 2026 | Exercise | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $18.4K | +3K +9.92% | 27,697 0.12% of shares | low |
| Jun 17, 2026 | Grant | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $0 | +454 +2.06% | 22,469 0.10% of shares | low |
| Jun 15, 2026 | Grant | TARA Protara Therapeutics, Inc. Stock Option (Right to Buy) | — | +31K | 31,000 0.05% of shares | low |
| Jun 17, 2026 | Grant | MDGL Madrigal Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | +766 | 766 <0.01% of shares | low |
| Feb 1, 2026 | Exercise | KNSA Kiniksa Pharmaceuticals International, plc Restricted Share Units | — | -683 -100.00% | 0 0.00% of shares | low |
| Feb 1, 2026 | Grant | KNSA Kiniksa Pharmaceuticals International, plc Restricted Share Units | — | +683 | 683 <0.01% of shares | low |
| Feb 1, 2026 | Exercise | KNSA Kiniksa Pharmaceuticals International, plc Class A Ordinary Share | — | +683 +3.70% | 19,157 0.01% of shares | low |
| Feb 23, 2026 | Exercise | MDGL Madrigal Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | -3K -100.00% | 0 0.00% of shares | low |
| Jan 26, 2026 | Exercise | MDGL Madrigal Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | -4K -100.00% | 0 0.00% of shares | low |